Back
Alarum Technologies Vs. Kymera Therapeutics Industry Stock Comparison
Buy
51
ALAR
Alarum Technologies
Last Price:
23.13
Seasonality Move:
-22.39%
Buy
67
KYMR
Kymera Therapeutics
Last Price:
43.81
Seasonality Move:
-6.51%
Buy
51
Alarum Technologies (ALAR)
is a Buy
Is Alarum Technologies a Buy, Sell or Hold?
- The current Alarum Technologies [ALAR] share price is $23.13. The Score for ALAR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALAR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $43.80. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALAR Stock Price Chart
What is Alarum Technologies's stock price today?
-
The Alarum Technologies share price today is $23.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALAR is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $43.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
ALAR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.39 | Sell |
Relative Strength Index (14 RSI): | 43.6 | Sell |
Chaikin Money Flow: | -13651 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.54 - 27.66) | Sell |
Bollinger Bands (100): | (22.69 - 35.47) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.08 | Buy |
Relative Strength Index (14 RSI): | 56.59 | Buy |
Chaikin Money Flow: | -25430 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.48 - 45.3) | Buy |
Bollinger Bands (100): | (32.4 - 41.52) | Buy |
ALAR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.94 | Buy |
20-day SMA: | 23.79 | Sell |
50-day SMA: | 30.53 | Sell |
200-day SMA: | 19.53 | Buy |
8-day EMA: | 22.59 | Buy |
20-day EMA: | 24.3 | Sell |
50-day EMA: | 27.51 | Sell |
200-day EMA: | 21.54 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.47 | Buy |
20-day SMA: | 42.87 | Buy |
50-day SMA: | 38.23 | Buy |
200-day SMA: | 33.07 | Buy |
8-day EMA: | 42.93 | Buy |
20-day EMA: | 42.2 | Buy |
50-day EMA: | 39.81 | Buy |
200-day EMA: | 34.21 | Buy |
Alarum Technologies Earnings Growth & ALAR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.04 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.38 per share.
Alarum Technologies Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |